Avastin slows progress of breast cancer in trial (Reuters)Reuters - The addition of Genentech Inc's cancer
drug Avastin to chemotherapy slows the progress of breast
cancer at two different doses, according to results of a large
international trial released on Saturday.
http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/cancer_breast_avastin_dc.html